from Stocks-Markets-Economic Times https://ift.tt/3qnTZ4a
Home »
Stocks-Markets-Economic Times
» AstraZeneca Pharma India Q2 results: Net profit declines 55% to Rs 12 cr
AstraZeneca Pharma India Q2 results: Net profit declines 55% to Rs 12 cr
from Stocks-Markets-Economic Times https://ift.tt/3qnTZ4a
Related Posts:
Digital outage hits HDFC Bank customers againIn December 2020, the RBI had barred HDFC Bank from new digital launches and issuance of fresh credit cards until it addressed its digital issues. The RBI had also asked the bank’s board to identify lapses and fix accountabil… Read More
Sensex up 68% in FY21, highest rise in 10 yearsA global pandemic notwithstanding, Dalal Street set several records during the financial year that ended on March 31, including a record rally beyond 52,500 points for the sensex, market capitalisation that neared the $3 tril… Read More
India’s current account ends in deficit in Q3 as demand risesThe critical measure of a country's external strength now stands at a surplus of 1.7 per cent of GDP for the first nine months of the fiscal year as against a deficit of 1.2 per cent in the year-ago period from Stocks-Market… Read More
HDFC raises FD rates upto 25 bpsFrom March 30, fixed deposits of 33-month duration will fetch 6.2% annualised returns. For 66-month deposits, the rate would be 6.6% and 6.65% for 99-month deposits. Senior citizens would get 25 basis points more. Distributor… Read More
Pine Labs eyes US IPO in 2022 with $5bn valuation Pine Labs, which provides digital payments and commerce solutions to merchants, has started working towards an IPO by March 2022 in the US, sources aware of the matter said. from Stocks-Markets-Economic Times https://ift.tt… Read More
0 Comments:
Post a Comment